相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Baricitinib in patients with moderate-tosevere atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)
Eric L. Simpson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis
Joseph F. Merola et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
Thomas Bieber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
Kristian Reich et al.
LANCET (2021)
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double- blind, randomised controlled phase 3 trials
Emma Guttman-Yassky et al.
LANCET (2021)
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
Andrew Blauvelt et al.
JAMA DERMATOLOGY (2021)
GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions
Nancy Santesso et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)
Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial
Susan Chan et al.
JAMA PEDIATRICS (2020)
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis A Phase 2b Randomized Clinical Trial
Emma Guttman-Yassky et al.
JAMA DERMATOLOGY (2020)
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis A Systematic Review and Network Meta-analysis
Aaron M. Drucker et al.
JAMA DERMATOLOGY (2020)
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
Jonathan Silverberg et al.
JAMA DERMATOLOGY (2020)
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial
Amy S. Paller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Eric L Simpson et al.
LANCET (2020)
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus
Kenji Kabashima et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis A Randomized Clinical Trial
Kristian Reich et al.
JAMA DERMATOLOGY (2020)
Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis: A Systematic Review
Megan Lam et al.
JAMA DERMATOLOGY (2020)
Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis
Romina Brignardello-Petersen et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2018)
Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials
Patrick Fleming et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial
Catherine Goujon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis
Aaron Mark Drucker et al.
BMJ OPEN (2018)
Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement
P. I. Spuls et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review
Su Golder et al.
PLOS MEDICINE (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatogy Life Quality Index (DLQI): Further Data
M. K. A. Basra et al.
DERMATOLOGY (2015)
The Harmonizing Outcome Measures for Eczema (HOME) Roadmap: A Methodological Framework to Develop Core Sets of Outcome Measurements in Dermatology
Jochen Schmitt et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials
Jochen Schmitt et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Guidelines of care for the management of atopic dermatitis
Robert Sidbury et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis
Milo A. Puhan et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
A randomized trial of methotrexate versus azathioprine for severe atopic eczema
Mandy Elvira Schram et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
Georgia Salanti et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Checking consistency in mixed treatment comparison meta-analysis
S. Dias et al.
STATISTICS IN MEDICINE (2010)
Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial
SJ Meggitt et al.
LANCET (2006)
Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial
J Berth-Jones et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis
H Granlund et al.
ACTA DERMATO-VENEREOLOGICA (2001)
分享论文
